60 related articles for article (PubMed ID: 35749755)
1. Matched Versus Mixed COVID-19 Vaccinations in Korean Solid Organ Transplant Recipients: An Observational Study.
Kang JM; Lee J; Huh KH; Joo DJ; Lee JG; Kim HR; Kim HY; Lee M; Jung I; Kim MY; Kim S; Park Y; Kim MS
Transplantation; 2022 Sep; 106(9):e392-e403. PubMed ID: 35749755
[TBL] [Abstract][Full Text] [Related]
2. Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
Liu X; Munro APS; Wright A; Feng S; Janani L; Aley PK; Babbage G; Baker J; Baxter D; Bawa T; Bula M; Cathie K; Chatterjee K; Dodd K; Enever Y; Fox L; Qureshi E; Goodman AL; Green CA; Haughney J; Hicks A; Jones CE; Kanji N; van der Klaauw AA; Libri V; Llewelyn MJ; Mansfield R; Maallah M; McGregor AC; Minassian AM; Moore P; Mughal M; Mujadidi YF; Belhadef HT; Holliday K; Osanlou O; Osanlou R; Owens DR; Pacurar M; Palfreeman A; Pan D; Rampling T; Regan K; Saich S; Saralaya D; Sharma S; Sheridan R; Stokes M; Thomson EC; Todd S; Twelves C; Read RC; Charlton S; Hallis B; Ramsay M; Andrews N; Lambe T; Nguyen-Van-Tam JS; Cornelius V; Snape MD; Faust SN;
J Infect; 2023 Jul; 87(1):18-26. PubMed ID: 37085049
[TBL] [Abstract][Full Text] [Related]
3. Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
Liu X; Munro APS; Feng S; Janani L; Aley PK; Babbage G; Baxter D; Bula M; Cathie K; Chatterjee K; Dejnirattisai W; Dodd K; Enever Y; Qureshi E; Goodman AL; Green CA; Harndahl L; Haughney J; Hicks A; van der Klaauw AA; Kwok J; Libri V; Llewelyn MJ; McGregor AC; Minassian AM; Moore P; Mughal M; Mujadidi YF; Holliday K; Osanlou O; Osanlou R; Owens DR; Pacurar M; Palfreeman A; Pan D; Rampling T; Regan K; Saich S; Serafimova T; Saralaya D; Screaton GR; Sharma S; Sheridan R; Sturdy A; Supasa P; Thomson EC; Todd S; Twelves C; Read RC; Charlton S; Hallis B; Ramsay M; Andrews N; Lambe T; Nguyen-Van-Tam JS; Cornelius V; Snape MD; Faust SN;
J Infect; 2022 Jun; 84(6):795-813. PubMed ID: 35405168
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational study.
Haase M; Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos-Araújo C; Veiga PM; Macario F
J Nephrol; 2022 Jun; 35(5):1467-1478. PubMed ID: 35084719
[TBL] [Abstract][Full Text] [Related]
5. Comparison of humoral immunogenicity in solid organ transplant recipients after third-dose mRNA vaccine with homologous or heterologous schedules: An observational study.
Kang JM; Lee J; Huh KH; Joo DJ; Lee JG; Kim HY; Lee M; Jung I; Kim MY; Kim S; Park Y; Kim MS
J Clin Virol; 2023 Feb; 159():105374. PubMed ID: 36592547
[TBL] [Abstract][Full Text] [Related]
6. Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Shaw RH; Greenland M; Stuart ASV; Aley PK; Andrews NJ; Cameron JC; Charlton S; Clutterbuck EA; Collins AM; Darton T; Dinesh T; Duncan CJA; Faust SN; Ferreira DM; Finn A; Goodman AL; Green CA; Hallis B; Heath PT; Hill H; Lambe T; Libri V; Lillie PJ; Morey E; Mujadidi YF; Payne R; Plested EL; Provstgaard-Morys S; Ramasamy MN; Ramsay M; Read RC; Robinson H; Screaton GR; Singh N; Turner DPJ; Turner PJ; White R; Nguyen-Van-Tam JS; Liu X; Snape MD;
J Infect; 2023 Jun; 86(6):574-583. PubMed ID: 37028454
[TBL] [Abstract][Full Text] [Related]
7. To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination.
Chiu NC; Chi H; Tu YK; Huang YN; Tai YL; Weng SL; Chang L; Huang DT; Huang FY; Lin CY
Expert Rev Vaccines; 2021 Oct; 20(10):1211-1220. PubMed ID: 34415818
[TBL] [Abstract][Full Text] [Related]
8. The humoral immune response to the BNT 162B2 vaccine in pediatrics on renal replacement therapy.
Alshami A; Bahbah H; Al Attas R; Aldokhi F; Azzam A
Pediatr Transplant; 2024 May; 28(3):e14712. PubMed ID: 38553800
[TBL] [Abstract][Full Text] [Related]
9. Magnitude and Duration of Serum Neutralizing Antibody Titers Induced by a Third mRNA COVID-19 Vaccination against Omicron BA.1 in Older Individuals.
Park JS; Jeon J; Um J; Choi YY; Kim MK; Lee KS; Sung HK; Jang HC; Chin B; Kim CK; Oh MD; Lee CS
Infect Chemother; 2024 Mar; 56(1):25-36. PubMed ID: 38014726
[TBL] [Abstract][Full Text] [Related]
10. Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.
Murray SM; Barbanti M; Campbell C; Brown A; Chen L; Dhanapal J; Tseu B; Pervaiz O; Peters L; Springett S; Danby R; Adele S; Phillips E; Malone T; Amini A; Stafford L; Deeks AS; Dunachie S; Klenerman P; Peniket A; Barnes E; Kesavan M
Br J Haematol; 2022 Aug; 198(4):668-679. PubMed ID: 35655410
[TBL] [Abstract][Full Text] [Related]
11. Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines.
Liu Y; Sánchez-Ovando S; Carolan L; Dowson L; Khvorov A; Jessica Hadiprodjo A; Tseng YY; Delahunty C; Khatami A; Macnish M; Dougherty S; Hagenauer M; Riley KE; Jadhav A; Harvey J; Kaiser M; Mathew S; Hodgson D; Leung V; Subbarao K; Cheng AC; Macartney K; Koirala A; Marshall H; Clark J; Blyth CC; Wark P; Kucharski AJ; Sullivan SG; Fox A
Vaccine; 2023 Nov; 41(48):7192-7200. PubMed ID: 37903679
[TBL] [Abstract][Full Text] [Related]
12. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients.
Karaba AH; Zhu X; Benner SE; Akinde O; Eby Y; Wang KH; Saraf S; Garonzik-Wang JM; Klein SL; Bailey JR; Cox AL; Blankson JN; Durand CM; Segev DL; Werbel WA; Tobian AAR
Transplantation; 2022 Apr; 106(4):835-841. PubMed ID: 35085183
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes related to immune enhancement caused by heterologous ChAdOx1-BNT162b2 vaccines in lymphocytes at single-cell resolution with machine learning methods.
Li J; Huang F; Ma Q; Guo W; Feng K; Huang T; Cai YD
Front Immunol; 2023; 14():1131051. PubMed ID: 36936955
[TBL] [Abstract][Full Text] [Related]
14. Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
Karaba AH; Zhou W; Li S; Aytenfisu TY; Johnston TS; Akinde O; Eby Y; Abedon AT; Alejo JL; Qin CX; Thompson EA; Garonzik-Wang JM; Blankson JN; Cox AL; Bailey JR; Klein SL; Pekosz A; Segev DL; Tobian AAR; Werbel WA
Clin Infect Dis; 2023 Feb; 76(3):e495-e498. PubMed ID: 35959783
[TBL] [Abstract][Full Text] [Related]
15. Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients.
Huh K; Kang M; Kim YE; Choi Y; An SJ; Seong J; Go MJ; Kang JM; Jung J
J Infect Dis; 2024 Apr; 229(4):1026-1034. PubMed ID: 38097377
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
Azamar-Llamas D; Arenas-Martinez JS; Olivas-Martinez A; Jimenez JV; Kauffman-Ortega E; García-Carrera CJ; Papacristofilou-Riebeling B; Rivera-López FE; García-Juárez I
PLoS One; 2024; 19(3):e0301198. PubMed ID: 38547193
[TBL] [Abstract][Full Text] [Related]
17. Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response.
Costard-Jäckle A; Schramm R; Fischer B; Rivinius R; Bruno R; Müller B; Zittermann A; Boeken U; Westenfeld R; Knabbe C; Gummert J
Clin Res Cardiol; 2023 Nov; 112(11):1506-1516. PubMed ID: 35994091
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated diseases after vaccinations with AZD1222, BNT-162b2, &/or mRNA-1273: An observational investigation of 78 patients.
Ou TS; Sun YS; Lai CC; Chen WS; Tsai HC; Chen MH; Chou CT; Chang FP; Peng YC; Tsai CC; Liao HT; Tsai CY
Int Immunopharmacol; 2024 Jan; 127():111455. PubMed ID: 38157699
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Vaccine Seroresponse Based on The Timing of The Primary Series; Pre- versus Post-Renal Transplantation.
Weinberg AR; Caeg CO; DePalma R; Hernandez F; Rogers JH; Ibrahim HN; Bynon SJ; Nigo M
Clin Transplant; 2023 Nov; 37(11):e15072. PubMed ID: 37434417
[TBL] [Abstract][Full Text] [Related]
20. Post-acute sequelae of COVID-19 in solid organ transplant recipients.
Sigler R; Covarrubias K; Chen B; Rubarth RB; Torosian K; Sanchez CR; Bharti A; DeGruttola V; Aslam S
Transpl Infect Dis; 2023 Dec; 25(6):e14167. PubMed ID: 37922371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
